Compounds > azacitidine

azacitidine and Immunologic Deficiency Syndromes

azacitidine has been researched along with Immunologic Deficiency Syndromes in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delmas, AL; Fields, CR; Jin, B; Liu, X; Peng, J; Qiu, J; Robertson, KD; Soo, HM; Tao, Q; Wu, W; Ying, J1
Ehrlich, M; Frady, A; Hernandez, R; Ji, W; Qu, GZ; Varela, M; Zhang, XY1
Kumar, A1
Kraakman, ME; Lambert, M; Schuurman, RK; van den Elsen, PJ; van Eggermond, MC1

Other Studies

4 other study(ies) available for azacitidine and Immunologic Deficiency Syndromes

ArticleYear
DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
    Human molecular genetics, 2008, Mar-01, Volume: 17, Issue:5

    Topics: Abnormalities, Multiple; Acetylation; Azacitidine; B-Lymphocytes; Case-Control Studies; Cell Line, Transformed; Cell Transformation, Viral; Cells, Cultured; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3B; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Developmental; Genes, Recessive; Histones; Humans; Hydroxamic Acids; Immunologic Deficiency Syndromes; Intellectual Disability; Male; Mutation; Neurons; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Time Factors

2008
DNA demethylation and pericentromeric rearrangements of chromosome 1.
    Mutation research, 1997, Sep-05, Volume: 379, Issue:1

    Topics: Adult; Azacitidine; B-Lymphocytes; Burkitt Lymphoma; Cell Line; Cell Line, Transformed; Centromere; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 1; Decitabine; DNA Methylation; DNA, Satellite; Face; Fibroblasts; Heterochromatin; Humans; Immunologic Deficiency Syndromes; Male; Stem Cells; Tumor Cells, Cultured

1997
Rett and ICF syndromes: methylation moves into medicine.
    Journal of biosciences, 2000, Volume: 25, Issue:3

    Topics: Abnormalities, Multiple; Animals; Azacitidine; Chromosomal Proteins, Non-Histone; Craniofacial Abnormalities; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA Methyltransferase 3B; DNA Mutational Analysis; DNA-Binding Proteins; Embryonic and Fetal Development; Female; Gene Expression Regulation, Developmental; Gene Silencing; Genes, Lethal; Genotype; Heterochromatin; Humans; Immunologic Deficiency Syndromes; Infant, Newborn; Male; Methyl-CpG-Binding Protein 2; Mice; Mutation, Missense; Phenotype; Repressor Proteins; Rett Syndrome; Sequence Deletion; Syndrome; X Chromosome

2000
The MHC class II deficiency syndrome: heterogeneity at the level of the response to 5-azadeoxycytidine.
    Research in immunology, 1990, Volume: 141, Issue:2

    Topics: Azacitidine; Cell Line, Transformed; Decitabine; DNA; Gene Expression Regulation; Genes, MHC Class II; HLA-D Antigens; Humans; Immunologic Deficiency Syndromes; Lymphocytes; Methylation; Promoter Regions, Genetic; Syndrome; Transcription, Genetic

1990